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Abstract
Background: Axillary implant location is an alternative implant location in patients for cardiac
implantable electronic devices (CIEDs) for the purposes of improved cosmetic outcome. The
impact from the patient's perspective is unknown. The purpose of this study was to compare scar
perception scores andquality of life (QOL) in pediatric patientswith axillaryCIED implant location
versus the standard infraclavicular approach.
Methods: This is a multicenter prospective study conducted at eight pediatric centers and it
includes patients aged from 8 to 18 years with a CIED. Patients with prior sternotomy were
excluded. Scar perception and QOL outcomes were compared between the infraclavicular and
axillary implant locations.
Results: A total of 141 patients (83 implantable cardioverter defibrillator [ICD]/58 pacemakers)
were included, 55 with an axillary device and 86 with an infraclavicular device. Patients with an
ICD in the axillary position had better perception of scar appearance and consciousness. Patients
in the axillary group reported, on average, a total Pediatric QOL Inventory score that was 6 (1, 11)
units higher than the infraclavicular group, after adjusting for sex and race (P= 0.02).
Conclusions: QOL is significantly improved in axillary in comparison to the infraclavicular CIED
position, regardless of device type. Scar perception is improved in patients with ICD in the axillary
position.
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1 BACKGROUND
Pacemakers and internal cardioverters/defibrillators (ICDs) arewidely
accepted therapies in the pediatric population. These devices are gen-
erally referred to cardiac implantable electronic devices (CIEDs). The
standard transvenous implant location is via an infraclavicular inci-
sion, typically in the left chest. This approach may produce a signif-
icant scar that tends to spread with healing and may be raised or
appears red. In addition, the contour of the device may be readily evi-
dent and these cosmetic changes may affect health-related quality of
life (HRQOL), especially in young patients who are concerned about
their body image. While alternative cardiac device implant locations
have been suggested, they did not appear to bewidely adopted.1,2
It is known that pediatric patients with chronic medical conditions
have lower HRQOL when compared to healthy controls.3–6 Patients
withCIEDs have significantly lowerHRQOLcompared to patientswith
mild congenital heart disease (CHD) and healthy controls.7–11 While
it could be suspected that lower HRQOL would be related to fac-
tors, such as device shocks, lifestyle modifications, or activity restric-
tions associated with underlying cardiac disease, these factors were
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not associated with QOL in a prior report.8 To our knowledge, no
priormanuscript has specifically evaluated surgical scar appearance or
location of the scar as possibly affecting QOL in pediatric pacemaker
and ICD populations. Cardiac rhythm devices are being implanted in
children with increased frequency.12,13 Improving cosmetic outcomes
from surgical scars may impact HRQOL and decrease the impact of
disease.2
The axillary implant location is themost commonly used alternative
approach for CIED implantation. With this approach, there are either
no scars or only a small scar on the patient's chest, with the larger
device scar being hidden in the axilla.14 Thepurpose of thismulticenter
investigation was to compare HRQOL and patient perceptions of sur-
gical scar comparing two different implant locations (infraclavicular vs
axillary) among childrenwith a CIED.
2 METHODS
2.1 Research design
This is a cross-sectional, multi-institutional study from eight tertiary
care pediatric cardiology centers. Institutional review board approval
was obtained at each site. Patient-parent pairs completed relevant
questionnaires at a single outpatient visit at routine visits (usual state
of health) after device placement. Data entry and quality control were
performed by the Data Coordinating Center, based at Cincinnati Chil-
dren's Hospital Medical Center (CCHMC). Statistical analysis was per-
formed at Children's Hospital Colorado.
2.2 Population
Demographic information (including self-reported ethnicity) was col-
lected through parent report. Clinical information was collected
through chart review. The primary diagnosis was that which resulted
in CIED implantation.
Patients were eligible for enrollment if they were able to speak
English, they were of age 8-18 years, and had a transvenous CIED.
Patients were excluded if they had complex CHD, a prior sternotomy
(including an epicardial CIED), thoracotomy or other significant scar-
ring not caused by transvenous CIED implantation, implantation in
the preceding 3 months, significant life events within the preceding
6 months (eg, serious illness [personal or family], death of family or
friends, divorce/separation, or discharge of defibrillator), significant
comorbid disease, or a diagnosed developmental delay that prohibited
them from being able to complete the patient forms.
Our patient populationwas also compared to a healthy control pop-
ulation similarly to as reported in a previously published study.8 This
healthy control population was obtained from the initial PedsQL psy-
chometric article and the PedsQL data from within the Pediatric Car-
diac Quality of Life inventory (PCQLI) Validation Study.6
2.3 Implantation procedure
Patientswere analyzedbasedonCIED implant location type (infraclav-
icular vs axillary). Patients in the infraclavicular grouphad implantation
of their CIED with a standard approach of a single incision in the infr-
aclavicular area and the device implanted either in prepectoral or
submuscular pocket.14 Implantation of an axillary device was per-
formed by using two different techniques.1,15 The first technique
involves making a small infraclavicular incision for lead placement
and an axillary incision for placement of the device.1 The second
technique involves accessing the axillary vein, followed by making a
4-6-cm incision along the posterolateral margin of the pectoralismajor
muscle,15 or making an incision along the anterior axillary line with
the device placed in the anterior chest under the pectoralis muscle.
Examples of the surgical scarring resulting from CIED procedures are
presented in Figure 1. It is important to note that the decision with
respect to device location or implant techniquewas determined by the
patient and the physician at the implanting center. Patients included
in this study had their devices implanted for >3 months prior to be
asked to fill out questionnaires. Patients were therefore not random-
ized to device location. Also of note is that some implanting centers
would utilize only one technique or would offer both. There was no
specific date at which a center changed from one technique to the
other.
2.4 Testing inventory
2.4.1 Patient scar assessment questionnaire (PSAQ)
The PSAQ (validated in adults) was used by patients to convey an
opinion of their linear scar.2 Adolescents (13-18 years) were asked
to evaluate the scar on five domains: appearance, symptoms, con-
sciousness, and satisfaction with appearance, and satisfaction with
symptoms. Each domain is evaluated independently. A higher score
reflects a poorer perception of the scar related to the domain being
evaluated.
2.4.2 Quality of life assessments
Patient-parent pairs completed the generic Pediatric QOL Inventory
(PedsQL) to assess patient andparent-proxyHRQOL. ThePedsQLgen-
erates a Total score, and Physical Health Summary and Psychological
Health Summary subscale scores. The Psychological Health Summary
score is a composite of emotional, social, and school functioning.16
Using existing published data on normal patients, the PedsQL data
generated by patients and parents from this study were compared
to those of healthy children.3 The maximum score for the PedsQL
Total, Physical and Psychological Health Summary, and Psychosocial
Health Summary subscale scores is 100. Children and adolescents
also completed the Self-Perception Profile for Children (SPPC) and
Self-Perception Profile for Adolescents (SPPA), respectively.17–19
In the QOL study of cardiac devices in pediatrics by Czosek et al.8,
having an implantable cardiac device was associated with lower QOL
inventory scoring. The authors report that key drivers of patient
QOL were the presence of an ICD and CHD. For patients, self-
perception was a key driver and for parents, behavioral issues were a
concern.
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F IGURE 1 Surgical scarring and device
location in patients with implantable cardiac
devices. Panel A shows a patient with an
implantable internal cardioverter defibrillator in
the standard infraclavicular area. In this patient,
the scar is stretched and is clearly visible.
Because of the body habitus, the contour of the
device is not evident as it would be in a smaller
patient. Panel B shows a patient with an
implantable internal cardioverter defibrillator
with a 2-incision axillary approach. There is a
small incision in the infraclavicular area which is
less visible than in the patient in Panel A. There
is a larger incision in the axillary area for the
placement of the device. Because it is under the
patient's arm, it is much less visible [Color figure
can be viewed at wileyonlinelibrary.com]
2.5 Statistical analysis
Patient and parent demographics between the axillary and infraclav-
icular groups were compared using t-tests and chi-square tests for
continuous and discrete variables, respectively. We considered four
outcome measures: PSAQ, PedsQL (Total, Physical Health Summary,
and Psychosocial Health Summary), SPPC, and SPPA. Two-sample
t-tests were used to assess whether there was a significant difference
in QOL between the axillary, infraclavicular, and control groups for
all patients, with a Bonferroni correction used to adjust for mul-
tiple comparisons. Paired t-tests were used to test the difference
between patient and parent assessments. Pearson correlation coef-
ficients between the PSAQ subscales and their corresponding global
assessment variables were used to assess internal validity.
Multivariable linear models for the total PedsQL score, the differ-
ence between patient and parent PedsQL scores and PSAQ scores
were used to test for an interaction between type of device and
location of device. We considered seven variables as potential con-
founders in our multivariable models: age at first diagnosis, duration
of device/time with scar, sex, race (white vs other), income (<50 000,
50-100 000, and>100 000), cardiac diagnosis (normal heart structure,
cardiomyopathy, andCHD) andparticipation in independent education
plans. Variables were included in the final model if they were signifi-
cantly associated with the outcome based on simple linear regression.
The significance was set at 0.05 and 0.017 for comparisons in PedsQL
between the axillary, infraclavicular, and healthy control groups. For
this comparison R version 3.1.1 software (R Foundation for Statistical
Computing, Vienna, Austria, http://www.R-project.org/) was used.
3 RESULTS
3.1 Patient demographics
One hundred and forty-one patients were enrolled in the study (2011-
2014). Axillary devices were implanted in 55 (39%) and infraclavicular
devices in 86 (61%) patients. A summary of device type and implant
location by center (blinded) is shown in Figure 2. Patient and parent
demographics comparing the axillary versus infraclavicular implant
location are presented in Table 1 and in Appendix Tables A and B for
F IGURE 2 Device type and implant location by center. ICD=
internal cardiac defibrillator; PM= pacemaker.
comparison of implant location by device. A greater proportion of
children with a device in the axillary location were in individualized
education programs (individualized objectives of a child intended
to help the child reach educational goals more easily) (P = 0.0008).
There was no significant difference between axillary and infraclavic-
ular groups with respect to maternal education (P = 0.44) or family
income (P= 0.46). There was no difference in the number of additional
catheter- based or minimally invasive cardiac procedures unrelated
to device or lead functionality (Appendix Table C). Additional cardiac
electrophysiologic procedures in both groups included generator
change, lead revisions, and device relocation.
3.2 Patient scar assessment questionnaire
All four subscales were moderately to strongly correlated with their
global assessment variables: appearance (rho = 0.6), conscious-
ness (rho = 0.74), satisfaction with appearance (rho = 0.85), and
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TABLE 1 Demographics of patients comparing axillary and infraclavicular device implant location
Overall (n= 141) Axillary (n= 55) Infraclavicular (n= 86) P value
Age at diagnosis, mean (SD) 9.3 (5.2) 10.2 (5.0) 8.7 (5.3) 0.10
Age at enrollment, mean (SD) 14.2 (2.8) 14.2 (3.1) 14.3 (2.7) 0.82
Time (years) with device, mean (SD) 2.7 (2.8) 2.1 (2.3) 3.2 (3.2) 0.02
Proportion of patients≥13 101/139 (73) 36 (65) 65 (77)
Sex, male 75 (52.8) 22 (41.5) 49 (57.7) 0.07
Device type, ICD 83 (58.8) 36 (65.4) 47 (54.7) 0.22
Race 0.08
White 116 (80) 40 (72.7) 73 (84.9)
All others 29 (20) 15 (27.3) 13 (15.1)
Education programs 0.0008
Individual education plan 37 (25.5) 23 (41.8) 14 (16.3)
Regular school 108 (74.5) 32 (58.2) 72 (83.7)
Family income 0.46
Less than $50 000 41 (30.4) 12 (23.5) 27 (33.7)
$50 000-$100,000 52 (38.5) 21 (41.2) 299 (6.3)
Greater than $100 000 42 (31.1) 18 (35.3) 24 (30.0)
Cardiac diagnosis
Normal heart structure 108 (74.4) 42 (76.3) 62 (72.1)
Cardiomyopathy 23 (15.9) 9 (16.4) 14 (16.3) 0.77
Congenital heart disease 14 (9.7) 4 (7.3) 10 (11.6)
Total cardiac EP procedures 0.37
0 106 (75) 42 (76) 64 (74)
1 23 (16) 10 (18) 13 (15)
2 7 (5) 3 (5) 4 (5)
3 5 (4) 0 (0) 5 (6)
Electrophysiologic diagnosisa 0.32
Sinus node dysfunction 9 (5) 2 (3) 7 (6)
Cardioinhibitory syncope 7 (4) 5 (8) 2 (2)
Second/third degree AV block 38 (22) 14 (22) 24 (22)
Ventricular tachycardias 90 (52) 34 (53) 56 (51)
Other 30 (17) 9 (14) 21 (19)
Infection 1 (1) 0 (0) 1 (1) 1
Complication 19 (13) 5 (9) 14 (16) 0.33
ICD 0.26
Primary prevention 58 (70) 28 (78) 30 (64)
Secondary prevention 25 (30) 8 (22) 17 (36)
ICD discharge 52/83 (63) 26 (72) 26 (55) 0.18
Number of appropriate discharges** 18/29 (62) 6/10 (60) 12/19 (63) 1
Median 2 (2, 5) 2 (1, 2) 3 (2, 6) 0.28
Number of inappropriate discharges** 10/28 (36) 5/10 (36) 5/18 (28) 0.47
Median 2 (1, 5) 1 (1, 2) 3 (2, 6) 0.29
*Unless otherwise indicated, all data is n (number) with %l.
**Median (interquartile range). P value fromWilcoxon rank sum test.
aMultiple diagnoses possible.
p<0.05 is statistically significant. AV= atrioventricular; ICD= implantable cardioverter defibrillator; EP= electrophysiology; IEP= individualized education
program; SD= standard deviation.
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F IGURE 3 PSAQ scores reported for appearance,
consciousness, satisfaction with appearance, and
satisfaction with symptoms. (A) Comparison of
infraclavicular and axillary patients. Patients with an
infraclavicular device scored significantly higher
(poorer scar perception) in the appearance (P= 0.01)
and consciousness (P= 0.006) domains when compared
to patients with an axillary device. (B) Comparison of
PSAQ scores by implant location in patients with an
ICD. Patients with an infraclavicular ICD scored
significantly higher (poorer scar perception) in the
appearance (P= 0.001), consciousness (P= 0.0008),
and satisfaction with appearance (P= 0.01) domains
when compared to those with an axillary ICD. (C)
Comparison of PSAQ scores by implant location in
patients with a pacemaker. There was no significant
difference in PSAQ scores in any domain when
comparing the axillary and infraclavicular group. ICD=
implantable cardioverter defibrillator; PSAQ= patient
scar assessment questionnaire. *Denotes statistical
significance
satisfaction with symptoms (rho = 0.83). Patient PSAQ scores are
reported in Figure 3.
Duration of device, race, and income were significantly associated
with at least one of the PSAQ subscales and were adjusted for in each
subscale's model. Age at first diagnosis, individual education plans,
and cardiac diagnosis were not significantly associated with any of the
subscales. The difference in satisfaction with appearance between
axillary and infraclavicular placement was significantly different
between the ICD and pacemaker groups. Within the ICD group,
there was no statistically significant difference between locations,
although patients in the axillary group had greater satisfaction with
the appearance of their scars compared to the infraclavicular group by
2 points (95% confidence interval [CI]: −4, 1). Within the pacemaker
group, patients in the axillary group were significantly less satisfied
with the appearance of their scars compared to the ICD group by
4 points (95% CI: 1, 8). After adjusting for device type, consciousness
was rated significantly more favorably in the axillary group relative to
the infraclavicular group by 2 points (95%CI:−3, 0). There was no sta-
tistically significant difference in appearance or the satisfaction with
symptoms between the two locations, after adjusting for device type.
3.3 Pediatric QOL Inventory (PedsQL)
Table 2 summarizes univariate and multivariable model results for
total PedsQL. In an unadjusted analysis, there was no difference in
patient PedsQL total or subscale scores between the axillary and
infraclavicular groups. Sex and cardiac diagnosis were significantly
associatedwith thePedsQL total score in univariate analysis. The asso-
ciation between race and PedsQL total score was not statistically sig-
nificant; however, we included it as a covariate in our adjusted model
based on the large effect size and previously reported importance.8
In the multivariable model, the difference between axillary and infra-
clavicular placement was not significantly different between the ICD
and pacemaker groups (interaction P = 0.603). Based on the adjusted
model (shown in Table 2), patients in the axillary group reported, on
average, PedsQL Total scores were 6 points higher than the infraclav-
icular group.
In an unadjusted analysis, patients assessed their quality of life to
be, on average, higher than their parents did (mean difference: 4.8,
95% CI: 2, 7.5) (P = 0.001). Race and cardiac diagnosis were signifi-
cantly associated with the difference in score between patients and
parent-proxy reporters. In an adjusted model assessing for the dif-
ference in PedsQL Total score between patients and parent-proxy
reporters, the interaction between device type and location was not
significant (P = 0.5). In the final multivariable model, there was no
difference between patient and parent-proxy reported PedsQL Total
score between the axillary and infraclavicular groups (P= 0.2).
In comparison to healthy controls, device patients andparent-proxy
reports had lower HRQOL regardless of device location (Figure 4).
Figure 5 shows ICD patients compared to healthy controls. Figure 6
shows axillary patients compared to healthy controls.
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TABLE 2 Univariate andmultivariable predictors of PedsQL
Univariate predictors Multivariable predictors
Variable Coefficient (95%CI) P value Coefficient (95%CI) P value
Sex (M vs F) 6.29 (1.51, 11.07) 0.01 7.4 (2.77, 12.03) 0.002
Race (White vs other) −5.89 (−12, 0.23) 0.06 −1.43 (−7.41, 4.54) 0.63
Cardiac diagnosis
Cardiomyopathy vs normal heart structure −8.85 (−15.47,−2.23) 0.01 −6.35 (−13, 0.29) 0.061
Congenital heart disease vs normal heart structure 4.23 (−3.64, 12.1) 0.29 3.54 (−3.9, 10.98) 0.34
Congenital vs cardiomyopathy 13.08 (3.56, 22.6) 0.008 9.9 (0.62, 19.2) 0.04
Location (axillary vs infraclavicular) 3.91 (−1.04, 8.87) 0.12 6.1 (1.38, 10.82) 0.01
Device type (Pacemaker vs ICD) 7.82 (3.05, 12.58) 0.002 7.18 (2.37, 12) 0.004
In each of the categories listed, the second category is the reference group. Coefficients are differences in the means. A negative number reflects a lower
quality of life. Adjusted and unadjusted linear regression coefficients are shown for each predictor that was included in the final multivariable model. Values
in parentheses are 95%Confidence intervals.
CI= confidence interval; F= female; ICD= internal cardiac defibrillator;M=male; PedsQL= Pediatric Quality of Life Inventory
F IGURE 4 Patient and parent-proxy reported Total,
Physical, and Psychosocial Health Summary PedsQL
scores comparing the axillary and infraclavicular implant
locations to healthy controls. (A) Comparison of PedsQL
scores comparing healthy controls to axillary or
infraclavicular devices patients. Patients with an
infraclavicular device reported a lower HRQOL in all
domains when compared to healthy controls (total and
physical: P< 0.0001, psychosocial: P= 0.001). Patients in
the axillary group only reported a lower HRQOL in the
physical and psychosocial domain when compared to
healthy controls (P= 0.001). There were no differences in
HRQOL between the axillary and infraclavicular groups.
(B) Comparison of PedsQL scores comparing healthy
controls to axillary or infraclavicular devices. Parents
whose child had an infraclavicular or axillary device
reported a lower HRQOL in all domains when compared to
healthy controls (P< 0.0001). There was no significant
difference in parent reported HRQOLwhen comparing the
axillary and infraclavicular locations. HRQOL=
health-related quality of life; PedsQL= Pediatric Quality of
Life Inventory. *Denotes statistical significance
3.4 SPPC and SPPA
None of the SPPS or SPPA subscale scores were significantly different
between the axillary and infraclavicular groups (Appendix Tables D, E,
and F).
4 DISCUSSION
This was a multicenter study evaluating patient scar perception and
QOL in children with a CIED. To our knowledge, this is the first study
comparing device implant location and cosmetic outcomes in children.
It is challenging to attempt to quantify a patient's perception of their
scar and of their perception of their CIED in general, as perhaps sepa-
rate from their underlying disease state. With the PSAQ, the patients
evaluate their scars on appearance, symptoms, consciousness, sat-
isfaction with appearance, and satisfaction with symptoms. In our
study, we show that patient scar perception appears to be impacted by
variables of time with a scar, race, device type, and family income. For
our primary research question to determine if axillary or infraclavic-
ular device placement contributes to improved patient outcomes, the
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F IGURE 5 Patient and parent-proxy reported Total,
Physical, and Psychosocial Health Summary PedsQL scores
comparing the axillary ICD and infraclavicular ICD implant
locations to healthy controls. (A) Comparisons of PedsQL
scores comparing healthy controls to patients with an ICD
in the axillary or infraclavicular position.When compared to
healthy controls, patients with an axillary ICD had a lower
HRQOL for the physical (P≤ 0.0001) domain.When
compared to healthy controls, patients with an
infraclavicular ICD had a lower HRQOL for all domains
(P< 0.0001). There was no significant difference between
HRQOL between the axillary and infraclavicular ICD. (B)
Comparisons of parent-reported PedsQL scores comparing
healthy controls to patients with an ICD in the axillary or
infraclavicular position. Parents whose child had an
infraclavicular or axillary device reported a lower HRQOL
in all domains when compared to healthy controls
(P< 0.0001). There was no significant difference between
parent reported HRQOL between the axillary and
infraclavicular ICD. ICD= implantable cardioverter
defibrillator; HRQOL= health-related quality of life;
PedsQL= Pediatric Quality of Life Inventory. *Denotes
statistical significance
results aremixed. Axillary placement of aCIED seems to lead to amore
favorable scar perception in patients with ICDs, with less conclusive
evidence for an influence in either direction for pacemakers. As ICDs
are larger devices than pacemakers andwould therefore require larger
surgical scars and also perhaps a larger noticeable device contour
under the skin, it wouldmake intuitive sense that device location in the
axillary position would be of greater importance to patients with ICDs
compared to patients with pacemakers. CIED location and device type
had little effect on satisfaction with scar symptoms.
In moving from simple scar perception and appearance, our study
further evaluated quality of life with the PedsQL score. Based on
the adjusted model, patients in the axillary group reported, on aver-
age, PedsQL Total scores were 6 points higher than the infraclavic-
ular group (95% CI: 1.38, 10.82) (P = 0.01). This would suggest that
axillary implant leads to a more favorable quality of life. In addition,
similar to prior studies,8 our patients with CIED scored significantly
lower than healthy controls. Thus, simply having a CIED negatively
affected patient assessment of their quality of life. Interestingly, in an
unadjusted analysis, patients reported a higher quality of life than their
parents, although this difference was no longer seen in the adjusted
analyses.Opportunities, therefore, exist to improve cosmesis andqual-
ity of life scores in children who have undergone implantation of a life-
saving CIEDs.
Czosek et al reported the impact of cardiac devices on the quality
of life in pediatric patients.8 Their main conclusions were that patients
with CIEDs had a lower quality of life compared to healthy controls
and patients with mild forms of CHD.8 Key drivers were the pres-
ence of an ICD and CHD. The differences between our study and this
prior study are that the patient population was much different. By
study design, we excluded any patient with a prior sternotomy, which
therefore excluded patients who had a prior epicardial pacemaker or
repaired CHD. In Czosek's study, most of the pacemaker patients had
epicardial systems, and ahighpercentageof the ICDpatients hadCHD.
Thus, a high percentage of their population had prior sternotomies.
While the axillary approachmay provide improvedQOLandpatient
scar perception, particularly for patientswith an ICD, a recentmultina-
tional retrospective study compared the standard infraclavicular and
axillary implant locationswith respect to device functionality and com-
plication rates. In this study, Rausch et al reported similar outcomes
with regards to lead performance at implantation, procedural compli-
cation rates, device pocket infections, and need for reintervention.14
Similarly, we show no differences in the number of additional cardiac
electrophysiological procedures providing insight into wire and device
characteristics.While the current study did not specifically investigate
repeat procedures for device generator changes or lead revisions, the
authorswould like to provide a few insights. In our experience, the two-
incisional axillary approach14 that includes the leads being implanted
in the standard infraclavicular area and then being tunneled to the
axilla where the CIED is placed has similar ease of subsequent CIED
surgery (such as generator change, lead extractions, etc.) compared
to the standard infraclavicular approach. In the two-incisional axillary
approach, the leads and the device are placed very near to the incision
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F IGURE 6 Patient and parent-proxy reported Total,
Physical, and Psychosocial Health Summary PedsQL
scores comparing the axillary pacemaker and
infraclavicular pacemaker implant locations to healthy
controls. (A) Comparisons of PedsQL scores of healthy
controls to patients with a pacemaker in the axillary or
infraclavicular position. There was no significant
difference in HRQOL between any of the groups for any
domain. (B) Comparisons of parent reported PedsQL
scores for healthy controls and patients with a pacemaker
in the axillary or infraclavicular position. There was no
significant difference in HRQOL between any of the
groups for any domain. HRQOL= health-related quality
of life; PedsQL= Pediatric Quality of Life Inventory
locations and techniques for device surgeries are nearly identical. In
the single incision axillary approach, however, there is a vertical inci-
sion at the anterior axilla and the device is advanced to a more ante-
rior location.With this approach, there can be two theoretic concerns:
(1) the venous access site is at a more distal location and thus there is
more length of lead to be addressed during lead extractions and (2) the
device is placed “deep” anddistant fromthe incisionwhichmakes locat-
ing the devicemore challenging during subsequent device surgeries.
Despite the similar device functionality and complication rate, one
potential reason for the lack of utilization of the alternative axillary
technique may be driven by concern for lead longevity with more
lead exposed to external trauma, and decreased focus on cosmetic
outcomes. In previous studies, clinicians have been found to per-
form poorly when asked to predict HRQOL in children with cardiac
disease,20 and that lack of understanding may have significant impli-
cations on their choice of implant location and interest in alternative
implant techniques.
Similar to this data, prior studies in patients with cardiac devices
have shown that those with an ICD generally have lower HRQOL for
both the generic and disease-specific inventories when compared to
pacemakers.8,9,21 The pacemaker group was younger than the ICD
group at initial implantation, and thus may be the reason there is less
impact of the scar on HRQOL. It is possible that younger patients are
less likely to be concerned with appearance and be used to the scar by
adolescence, compared to the adolescent who has a new scar to adjust
to.
While scar perception was demonstrated to be an important factor,
it is unlikely to be the only mechanism affecting HRQOL. Specifically,
poorer scar perception in the ICD group as a whole, and in the ICD
infraclavicular group, but not in the pacemaker group, may be con-
founded by factors related to the disease necessitating implantation
and the overall severity of the underlying disease process. In addition,
based on the lack of difference in scores for the PSAQ satisfactionwith
symptoms subscale, it is unlikely that pain, is affecting scar perception.
The impact of scar appearance, consciousness, and satisfaction with
appearance appear to play a much bigger role in scar perception. Fur-
thermore, worse HRQOL in patients with an ICD may be confounded
by potential for shock as well as additional activity-based restrictions.
This is further suggested by the fact that the ICD group scored sig-
nificantly lower in the physical domains and in the disease impact and
psychosocial score in the PCQLI inventory. We attempted to control
for disease severity and its impact onHRQOLby not including patients
who had experienced a recent life-altering event. Importantly, though,
there was no significant difference in the proportion of patients who
had a device shock between the axillary and infraclavicular group.
This study has several important limitations. Factors related to
lower scar perception in the ICD group could not be elucidated from
this study. The reason for the lower scar perception of the axillary
pacemaker group compared to the infraclavicular pacemaker group is
unclear, and could not be assessed using selected study inventories.
Blinded review of scars could not be performed as many of the pho-
tographs obtained were of insufficient quality. We did not compare
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HRQOLbetween pacemakers and ICDs by device position due to small
sample size in those specific groups. The PSAQ is validated in adults,
andwe used it in adolescents.
5 CONCLUSIONS
CIED implant location and type appear to have some effect on scar
perception and quality of life as assessed by the PSAQ and HRQOL
in both the generic and cardiac specific inventories, with the axillary
group having better scar perceptionwhen compared to the infraclavic-
ular group for the ICD group in particular. The axillary implant location
can improveoverall quality of life and can improve scar perceptionwith
the ICD device.
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APPENDIX: Table A. Comparison of axil lary ICD and infraclavicular ICD
Axillary ICD (n= 36) Infraclavicular ICD (n= 47) P Value
Age at diagnosis, mean (SD) 11.7 (3.9) 10.5 (4.9) 0.26
Age at enrollment, mean (SD) 15.1 (2.5) 14.7 (2.4) 0.45
Proportion of patients≥13 29 (81) 36 (80)
Sex, Male 17 (48.6) 26 (56.5) 0.48
Race 0.15
White 27 (75) 41 (87.2)
All others 9 (25) 6 (12.8)
Kid's education programs 0.01
Special program (IEP) 16 (44.4) 9 (19.2)
Regular school 20 (55.6) 38 (80.8)
Maternal education 0.34
Less than high school 2 (5.7) 2 (4.6)
High school graduate 7 (20.0) 10 (23.3)
Partial college or trade school 13 (37.1) 20 (46.6)
College graduate 6 (17.2) 9 (20.9)
Postgraduate degree 7 (20.0) 2 (4.6)
Income 0.07
Less than $50 000 6 (17.7) 17 (41.4)
$50,000-$100 000 15 (44.1) 15 (36.6)
Greater than $100 000 13 (38.2) 9 (22.0)
Cardiac diagnosis 0.79
Normal heart structure 23 (63.9) 31 (66.0)
Cardiomyopathy 9 (25.0) 13 (27.6)
Congenital heart disease 4 (11.1) 3 (6.4)
Total cardiac procedures 0.48
0 34 (94.4) 39 (83)
1 1 (2.8) 4 (8.4)
2 1 (2.8) 2 (4/3)
3 0 (0) 2 (4.3)
Electrophysiologic diagnosis 0.43
Sinus node dysfunction 35 (97.2) 47 (100)
Cardioinhibitory syncope 1 (91.2) 0 (0)
Second-degree AV block 0 (0) 0 (0)
Third-degree AVBlock 0 (0) 0 (0)
All Others 0 (0) 0 (0)
ICD discharge 26 (72.2) 26 (55.3) 0.17
*Unless otherwise indicated, all data is n (number) with %. p< 0.05 is statistically significant.
AV= atrioventricular; ICD= implantable cardioverter defibrillator; IEP= individualized education program; SD= standard deviation.
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APPENDIX: Table B. Comparison of axil lary and infraclavicular pacemaker
Age at diagnosis, mean (SD) Axillary pacemaker (n= 19) Infraclavicular pacemaker (n= 39) PValue
Age at enrollment, mean (SD) 7.4 (5.6) 6.6 (5.0) 0.55
Proportion of patients≥13 12.4 (3.5) 13.8 (2.9) 0.11
Sex, Male 7 (37) 29 (74)
Race 0.03
White 5 (27.8) 23 (59.0)
All others
Kid's education programs 0.03
Special program (IEP) 12 (63.2) 34 (87.2)
Regular school 7 (36.8) 5 (12.8)
Maternal education 0.77
Less than high school 1 (5.5) 1 (2.6)
High school graduate 3 (16.7) 6 (15.8)
Partial college or trade school 3 (16.7) 12 (31.6)
College graduate 8 (44.4) 14 (36.8)
Postgraduate degree 3 (16.7 5 (13.2
Income 0.72
Less than $50 000 6 (35.3) 10 (25.6)
$50 000-$100 000 6 (35.3) 14 (35.9)
Greater than $100 000 5 (29.4) 15 (38.5)
Cardiac diagnosis 0.08
Normal heart structure 19 (100) 31 (79.5)
Cardiomyopathy 0 (0) 1 (2.5)
Congenital heart disease 0 (0) 7 (18.0)
Total number of cardiac procedures 0.01
0 19 (100) 26 (66.7)
1 0 (0) 12 (30.8)
2 0 (0) 1 (2.5)
3 0 (0) 0 (0)
Electrophysiologic diagnosis 0.18
Sinus node dysfunction 4 (21.1) 14 (35.9)
Cardioinhibitory syncope 3 (15.8) 2 (5.1)
Second-degree AV block 0 (0) 4 (10.3)
Third-degree AV block 0 (0) 0 (0)
All others 12 (63.1) 19 (48.7)
*Unless otherwise indicated, all data is n (number) with %.
AV= atrioventricular; IEP= individualized education program; SD= standard deviation.
APPENDIX: Table C. Summary of additional catheter based or minimally invasive cardiac procedures unrelated to
device or lead functionality
Procedure 1 Procedure 2
Axillary Infraclavicular Axillary Infraclavicular
Cardiac catheterizationwith device closure of an ASD or PDA 1 (100) 3 (43) 0 (0) 0 (0)
Endomyocardial biopsy 0 (0) 2 (29) 0 (0) 0 (0)
Implantation of anothermonitoring device (loop recorder) 0 (0) 2 (29) 0 (0) 0 (0)
Ablation procedure 0 (0) 0 (0) 0 (0) 2 (100)
*All data is n (number) with %.
ASD= atrial septal defect; PDA= patent ductus arteriosus.
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APPENDIX: Table D. All Patients: SPPC and SPPA
Variable Axillary (n= 55) Infraclavicular (n= 86) PValue
Athletic competence 2.8 ± 0.7 2.9 ± 0.7 0.35
Behavioral conduct 3.2 ± 0.7 3.2 ± 0.6 0.78
Close friends 3.2 ± 0.8 3.3 ± 0.6 0.64
Global self-worth 3.4 ± 0.5 3.3 ± 0.6 0.10
Physical appearance 3.1 ± 0.7 3 ± 0.7 0.54
Romantic appeal 2.9 ± 0.7 3 ± 0.6 0.54
Social acceptance 3.2 ± 0.6 3.2 ± 0.6 0.56
*Values are presented asmean ± standard deviation.
SPPC = athletic competence, behavioral conduct, global self-worth, physical appearance; SPPA = athletic competence, behavioral conduct, close friends,
global self -worth, physical appearance, romantic appeal, social acceptance; domains denoted are from the “What I am Like,” portion of the SPPC and SPPA.
APPENDIX: Table E. ICD: SPPC and SPPA
Variable Axillary (n= 36) Infraclavicular (n= 47) PValue
Athletic competence 2.8 ± 0.8 2.9 ± 0.7 0.67
Behavioral conduct 3.1 ± 0.7 3 ± 0.7 0.83
Close friends 3.2 ± 0.9 3.3 ± 0.6 0.57
Global self-worth 3.4 ± 0.5 3.2 ± 0.6 0.15
Physical appearance 3.1 ± 0.7 3.1 ± 0.7 0.92
Romantic appeal 2.9 ± 0.7 3 ± 0.6 0.44
Social acceptance 3.2 ± 0.6 3.2 ± 0.6 0.72
*Values are presented asmean ± standard deviation.
SPPC = athletic competence, behavioral conduct, global self-worth, physical appearance; SPPA = athletic competence, behavioral conduct, close friends,
global self -worth, physical appearance, romantic appeal, social acceptance; domains denoted are from the “What I am Like,” portion of the SPPC and SPPA.
APPENDIX: Table F. Pacemaker: SPPC and SPPA
Variable Axillary (n= 19) Infraclavicular (n= 39) PValue
WIAL_SCHOLASTIC 3.1 ± 0.7 3.1 ± 0.7 0.72
Athletic competence 2.8 ± 0.6 3 ± 0.7 0.34
Behavioral conduct 3.4 ± 0.5 3.3 ± 0.5 0.42
Close friends 3.2 ± 0.6 3.2 ± 0.7 0.85
Global self-worth 3.5 ± 0.5 3.3 ± 0.6 0.36
Physical appearance 3.2 ± 0.7 3 ± 0.7 0.28
Romantic appeal 2.9 ± 0.7 2.9 ± 0.7 0.94
Social acceptance 3.3 ± 0.6 3.2 ± 0.7 0.58
*Values are presented asmean ± standard deviation.
SPPC = athletic competence, behavioral conduct, global self-worth, physical appearance; SPPA = athletic competence, behavioral conduct, close friends,
global self -worth, physical appearance, romantic appeal, social acceptance; domains denoted are from the “What I am Like,” portion of the SPPC and SPPA.
